by Moon Hyewon
Published 13 May.2026 17:45(KST)
Ildong Pharmaceutical announced on May 13 that its consolidated operating profit for the first quarter of this year was 9.2 billion won, marking a 120% increase compared to the same period last year.
Sales reached 142 billion won, up 4.4% year-on-year, and net profit for the period surged by 1,376% to 7.4 billion won.
A representative from Ildong Pharmaceutical explained, "Our main business sectors—including prescription drugs, over-the-counter medicines, and healthcare—showed balanced growth." The representative added, "Operating profit also increased, driven by improvements in the cost-to-sales ratio resulting from cost innovation."